How many people are employed by TORM?
Ultragenyx Pharmaceutical Inc. is a commercial-stage biopharmaceutical enterprise focused on the development and commercialization of novel, life-transforming therapies for rare and ultra-rare genetic diseases. According to official corporate financial reports and annual SEC disclosures, the enterprise employs approximately 1,371 people globally. This specialized scientific and medical workforce includes researchers, clinical trial directors, regulatory specialists, and commercial teams distributed across research facilities and corporate offices in North America, Europe, and international markets.
Related FAQs
Yes, TC Energy Corporation (trading under the ticker TRP) has executed specific corporate share adjustments in its history, such as structural share distribution ratios linked to corporate spin-offs and asset separations (including the spinoff of ...
Trustmark Corporation operates as a regional financial services company providing comprehensive banking, wealth management, and insurance solutions, primarily across the southeastern United States. When compared to massive nationwide banking monol...
Tutor Perini Corporation is a prominent civil, building, and specialty construction enterprise delivering complex infrastructure, transportation, healthcare, and large-scale commercial building projects primarily throughout North America. Accordin...
Malaysia's telecommunications sector features a competitive market structure regulated by the Malaysian Communications and Multimedia Commission (MCMC), comprising a core group of major national telecommunications operators alongside dozens of spe...